Ashley Nguyen, Jie Zhou, Thomas Prior, Joseph Weidman, Sangmin Lee, Pansy Minnick, Daniel Jonathan, Caroline Hodin, Brandi Hilder, Nikki Daskalakis, Mahesh Samtani, Nahor Haddish-Berhane, Indrajeet Singh. "Clinical pharmacology strategies to support dose optimization of the recommended Phase 2 dose regimen of JNJ-5322, a BCMA×GPRC5D×CD3 trispecific antibody, in Relapsed/Refractory multiple myeloma." Blood, 2025. doi:10.1182/blood-2025-4054